Clinical Trials Directory

Trials / Completed

CompletedNCT02979210

Infant Fecal Insult Study

Fecal Insult Study: An Exploratory Study to Evaluate the Microbial Consortia and Skin Barrier Function After Exposure to Artificial Fecal Irritants

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
24 (actual)
Sponsor
Kimberly-Clark Corporation · Industry
Sex
Female
Age
18 Years – 40 Years
Healthy volunteers
Accepted

Summary

The rationale for the study is to better understand the dynamics of skin microflora following skin barrier disruption in an adult dermatitis model. The results from this study will provide insights in the complex interaction between skin microbiome and epidermis under normal and disease conditions

Conditions

Interventions

TypeNameDescription
OTHERArtificial Fecal Insultprotease/bile acid cocktail 200 microliters (1500 µg/ml trypsin/chymotrypsin protease mixture, 6.5 mg/ml cholic acid sodium, 6.2 mg/ml deoxycholic acid sodium, and 3.1 mg/ml chenodeoxycholic acid sodium in phosphate buffered saline
OTHERPhosphate Buffered Saline200 microliters of phosphate buffered saline

Timeline

Start date
2016-11-01
Primary completion
2017-01-26
Completion
2017-02-01
First posted
2016-12-01
Last updated
2017-08-18

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02979210. Inclusion in this directory is not an endorsement.